| Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. | liver, |
| Inactivation of the VHL tumor suppressor gene is a genetic change in the tumorigenic pathway of clear-cell renal cell carcinoma and may occur at an early or first step in the tumorigenic pathway rather than as a late event. | kidney, |
| Jade-1 protein is a novel candidate regulatory factor in Von Hippel Lindau-mediated renal tumor suppression | kidney, |
| Von Hippel-Lindau tumor suppressor protein transforms human neuroblastoma cells into functional neuron-like cells. | neuroblastoma, |
| Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene. | kidney, |
| Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. | esophageal, |
| PTHrP is an essential growth factor for clear cell renal carcinoma and is a novel target for the von Hippel-Lindau tumor suppressor protein. | kidney, |
| The von Hippel-Lindau tumor suppressor gene and kidney cancer. | kidney, |
| The interplay between the functional von Hippel-Lindau tumor suppressor and CA IX/CA XII in colorectal tumors seems rather | colorectal, |
| Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma | kidney, |
| von Hippel Lindau tumor suppressor has a role in iron homeostasis in renal carcinoma cells | kidney, |
| in pancreatic cancer cells, the p38-mediated phosphorylation of HIF-1alpha contributed to the inhibition of HIF-1alpha and von Hippel-Lindau tumor suppressor protein interaction during ischemia | pancreatic, |
| Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. | kidney, |
| The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells. | kidney, |
| In transfected cells and KSHV-infected B lymphoma cells, KSHV-encoded latency-associated nuclear antigen (LANA) expression stimulates degradation of tumor suppressors von Hippel-Lindau and p53. | lymphoma, |
| Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase | liver, |
| von Hippel-Lindau tumor suppressor protein has a role in clear cell renal carcinoma | kidney, |
| The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma. | kidney, |
| Loss of von Hippel-Lindau tumor suppressor gene function occurs in familial and most sporadic clear cell renal cell carcinoma, resulting in the aberrant expression of genes that control cell proliferation, metabolism, invasion and angiogenesis. | kidney, |
| von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR. | thyroid,kidney, |